Streamlining the Use of Mifepristone for Early Pregnancy Loss Across a Large Health Care System Sets the Stage for Rapid Expansion of Medication Abortion Access in a Post-Roe Environment.

The article discusses the establishment of processes to facilitate the use of mifepristone for early pregnancy loss (EPL) within a large healthcare system, with the goal of expanding access to medication abortion in a post-Roe environment. The process involved collaboration with various stakeholders, including pharmacy purchasing teams, clinic management, education teams, and information technology.